Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Mar 19, 2010

Premium

GE Healthcare this week launched the Sensor Chip CM7 for use on the company's Biacore systems.

The chip has the high immobilization capacity required to support fragment-based screening of small molecules, the company said in a statement. In addition to high signal-to-noise ratios resulting in improved screening data quality, the chip provides improved detection in cases where immobilization levels are unfavorable, including low target protein concentration levels, or proteins that are sensitive to optimal immobilization conditions.

The Sensor Chip CM7 has a carboxymethylated dextran matrix covalently attached to gold film. It is capable of binding proteins, nucleic acids, carbohydrates, or small molecules to carboxyl groups on the sensor surface.


Agilent Technologies said this week that its 1290 Infinity LC is equipped with the 1290 Infinity Diode Array Detector, a new optical design based on the company's Max-Light flow cell with optofluidic waveguides.

As a result, the system has higher levels of UV detection sensitivity and baseline robustness. A path length of 60 millimeters achieves sensitivity 10 times greater than the current industry-leading 1200 Series DAD, the company said in a statement.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.